Clinical Trial Detail

NCT ID NCT03217071
Title Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sue Yom
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.